Boehringer Ingelheim names Baiker as new U.S. president
RIDGEFIELD, Conn.– Boehringer Ingelheim announced that its U.S. president and chief executive officer Paul Fonteyne will retire and Wolfgang Baiker has been appointed to succeed him, effective March 1. The position will be based at the pharmaceutical company’s U.S. headquarters in Ridgefield. “I am thrilled to return to the U.S. to lead this organization and
